
Azitra, Inc.
AZTRHealthcare|Biotechnology|US
$0.73
+0.01 (+1.02%)
DCF Value
$2.87
Tangible Book / Share
$3.55
Cash / Share
$3.49
Next Earnings Report
Nov 11, 2026
EPS est. -$0.25
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Sep 28, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Jul 2027
Est. completion
P1P2EGFR Inhibitor-associated Rash
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
NCT06830863n=32
Recent Press Releases
Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors
Oct 29, 2026 · PRNewsWire
Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin
Oct 26, 2026 · PRNewsWire
Azitra, Inc. Announces Reverse Stock Split
Oct 16, 2026 · PRNewsWire
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
Oct 1, 2026 · PRNewsWire
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · PRNewsWire
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
Aug 21, 2026 · PRNewsWire
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
Aug 12, 2026 · PRNewsWire
SEC Filings (97)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 29, 2026 | 8-K | Material event | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 22, 2026 | 8-K | Material event | DocumentIndex |
| Oct 1, 2026 | 8-K | Material event | DocumentIndex |
| Sep 28, 2026 | 8-K | Material event | DocumentIndex |
| Sep 28, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 8, 2026 | 8-K | Material event | DocumentIndex |
| Aug 21, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 15, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 24, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Jun 22, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 17, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 4, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 4, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | EFFECT | DocumentIndex | |
| May 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 21, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 8, 2026 | ARS | Annual report to holders | DocumentIndex |
| May 8, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 23, 2026 | 8-K | Material event | DocumentIndex |
| Mar 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 5, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 27, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 6, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Feb 6, 2026 | 8-K | Material event | DocumentIndex |
| Jan 30, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jan 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 23, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |